Trial · NCT00293462
Adverse events114
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 114
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Transfusion | Blood and lymphatic system disorders | Arm I: GM-CSF Group (GG) | 2 | 29 | 2 |
| other | Transfusion | Blood and lymphatic system disorders | Arm II: Salt & Soda Group (SS) | 0 | 28 | 0 |
| other | Transfusion | Blood and lymphatic system disorders | Arm III: Salt & Soda Switched to GM-CSF (SG) | 0 | 28 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Arm I: GM-CSF Group (GG) | 0 | 29 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Arm II: Salt & Soda Group (SS) | 0 | 28 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Arm III: Salt & Soda Switched to GM-CSF (SG) | 1 | 28 | 1 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm I: GM-CSF Group (GG) | 1 | 29 | 1 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm II: Salt & Soda Group (SS) | 1 | 28 | 1 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm III: Salt & Soda Switched to GM-CSF (SG) | 1 | 28 | 1 |
| other | Sinus Tachycardia | Cardiac disorders | Arm I: GM-CSF Group (GG) | 1 | 29 | 1 |
| other | Sinus Tachycardia | Cardiac disorders | Arm II: Salt & Soda Group (SS) | 0 | 28 | 0 |
| other | Sinus Tachycardia | Cardiac disorders | Arm III: Salt & Soda Switched to GM-CSF (SG) | 0 | 28 | 0 |
| other | Stomach pain | Gastrointestinal disorders | Arm I: GM-CSF Group (GG) | 1 | 29 | 1 |
| other | Stomach pain | Gastrointestinal disorders | Arm II: Salt & Soda Group (SS) | 0 | 28 | 0 |
| other | Stomach pain | Gastrointestinal disorders | Arm III: Salt & Soda Switched to GM-CSF (SG) | 0 | 28 | 0 |
| other | Constipation | Gastrointestinal disorders | Arm I: GM-CSF Group (GG) | 0 | 29 | 0 |
| other | Constipation | Gastrointestinal disorders | Arm II: Salt & Soda Group (SS) | 0 | 28 | 0 |
| other | Constipation | Gastrointestinal disorders | Arm III: Salt & Soda Switched to GM-CSF (SG) | 1 | 28 | 1 |
| other | Fatigue | General disorders | Arm I: GM-CSF Group (GG) | 1 | 29 | 1 |
| other | Fatigue | General disorders | Arm II: Salt & Soda Group (SS) | 1 | 28 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00293462/events